购物车
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Autophagy
    (4)
  • Bcr-Abl
    (4)
  • Antifungal
    (1)
  • Apoptosis
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (3)
  • 5日内发货
    (2)
  • 35日内发货
    (2)
  • 1-2周
    (2)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "nilotinib"的结果
筛选
搜索结果
TargetMol产品目录中 "

nilotinib

"的结果
  • 抑制剂&激动剂
    11
    抑制剂&激动剂
  • 染料试剂
    1
    染料试剂
  • 同位素
    2
    同位素
  • 标准品
    1
    标准品
  • Nilotinib
    尼洛替尼, 尼罗替尼, Tasigna, AMN107
    T1524641571-10-0
    Nilotinib (AMN107) 是一种 Bcr-Abl 酪氨酸激酶抑制剂,具有口服活性。Nilotinib 具有抗肿瘤活性,可以用于治疗 Imatinib 耐药的慢性粒细胞性白血病 (CML)。
    • ¥ 282
    现货
    规格
    数量
    TargetMol | Citations 客户已引用
  • Nilotinib dihydrochloride dihydrate
    T710681277165-20-4
    Nilotinib dihydrochloride dihydrate is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
    • ¥ 10600
    1-2周
    规格
    数量
  • Nilotinib monohydrochloride monohydrate
    尼洛替尼盐酸盐一水合物, 尼罗替尼中间体, Nilotinib (monohydrochloride monohydrate), AMN107 (monohydrochloride monohydrate)
    T2147923288-90-8
    Nilotinib monohydrochloride monohydrate (Nilotinib (monohydrochloride monohydrate)) 是酪氨酸酶抑制剂,有效抑制 BCR-ABL 及其突变体。
    • ¥ 115
    现货
    规格
    数量
  • Nilotinib-d6
    AMN107 D6
    T122241268356-17-7
    Nilotinib D6 is a deuterium labeled Nilotinib which is an orally available inhibitor of Bcr-Abl tyrosine kinase ,and with antineoplastic activity.
    • ¥ 3970
    35日内发货
    规格
    数量
  • Nilotinib hydrochloride dihydrate
    T68338923289-71-8
    Nilotinib hydrochloride dihydrate is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
    • ¥ 10600
    5日内发货
    规格
    数量
  • Nilotinib N-oxide
    T711441246817-85-5
    Nilotinib N-oxide is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
    • ¥ 10600
    6-8周
    规格
    数量
  • Nilotinib hydrochloride
    尼罗替尼盐酸盐, AMN-107 HCl
    T22378923288-95-3
    Nilotinib hydrochloride(AMN-107 HCl) 是一种可口服的 Bcr-Abl 酪氨酸激酶抑制,具有抗肿瘤活性,可用于调节神经炎症和认知障碍,可用于研究慢性骨髓性白血病。
    • ¥ 279
    现货
    规格
    数量
  • Nilotinib (Standard)
    尼洛替尼(标准品)
    TMSM-3451641571-10-0
    Nilotinib (Standard) 是一种可用于分析的标准物质,通常用作 Nilotinib 的研究和分析中参考的标准样品。Nilotinib (AMN107) 是一种 Bcr-Abl 酪氨酸激酶抑制剂,具有口服活性。Nilotinib 具有抗肿瘤活性,可以用于治疗 Imatinib 耐药的慢性粒细胞性白血病 (CML)。
    • ¥ 1130
    5日内发货
    规格
    数量
  • Cidofovir sodium
    T71066127749-27-3
    Cidofovir sodium is the salt form of Cidofovir, a Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor that is an injectable antiviral medication primarily used as a treatment for cytomegalovirus (CMV) retinitis in people with AIDS. The mechanism of action of cidofovir is as a DNA Polymerase Inhibitor. The chemical classification of cidofovir anhydrous is Nucleoside Analog.
    • ¥ 10600
    1-2周
    规格
    数量
  • Tebuconazole-d9
    T711421246818-83-6
    Tebuconazole-d9 is intended for use as an internal standard for the quantification of tebuconazole by GC- or LC-MS. Tebuconazole is a triazole fungicide that is active against both seed and foliar fungi. It inhibits 14α-demethylase isolated from U. maydis and S. bicolor with IC50 values of 0.05 and 0.16 nM, respectively. It inhibits the androgenic effect of the androgen receptor agonist DHT (IC20 = 2.89 µM) and is cytotoxic (EC20 = 38.9 µM) in an MDA-kb2 assay. Tebuconazole (50 and 100 mg/kg per day) administered during gestation reduces testosterone levels and increases testicular levels of progesterone and 17α-hydroxyprogesterone in male rat fetuses. It has a feminizing effect on male pups and a virializing effect on female pups. When administered to rats gestationally through postnatal day 42, tebuconazole (20 and 60 mg/kg per day) leads to cell death of pyramidal cells in the CA3-4 region of the hippocampus and layer V of the cortex concomitant with impairment in learning......
    • ¥ 4300
    35日内发货
    规格
    数量
  • SGX393
    T715811030610-86-6
    SGX393 is an inhibitor of the CML mutant Bcr-AblT315I, thereby preempting in vitro resistance when combined with nilotinib or dasatinib.
    • ¥ 10600
    6-8周
    规格
    数量
没有更多数据了